Barr pharmaceutical, barr pharmaceutical.#Barr #pharmaceutical


Posted On Feb 13 2018 by

Fentanyl

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Barr pharmaceutical

Structure for DB00813 (Fentanyl)

Barr pharmaceutical

Barr pharmaceutical Barr pharmaceutical Barr pharmaceutical Barr pharmaceutical

Monoisotopic: 336.220163528 Chemical Formula C22H28N2O InChI Key PJMPHNIQZUBGLI-UHFFFAOYSA-N InChI

Pharmacology

For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy.

Structured Indications Learn More” title=”About Structured Indications” id=”structured-indications-info” class=”drug-info-popup” href=”javascript:void(0);”>

  • Breakthrough Cancer Pain
  • Severe Pain
  • Moderate Pain

Pharmacodynamics

Fentanyl is an opioid analgesic. Fentanyl interacts predominately with the opioid mu-receptor but also binds to kappa and delta-type opioid receptors. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, Fentanyl exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Fentanyl may increase the patient s tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Fentanyl depresses the respiratory centers, depresses the cough reflex, and constricts the pupils.

Mechanism of action

Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Fentanyl s analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hypopolarization and reduced neuronal excitability.


Last Updated on: February 13th, 2018 at 10:40 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *